Accueil > Actualité
Actualite financiere : Actualite bourse

Ipsen: Dysport authorisation extended in UK

( - Ipsen announces that the MHRA in the UK has extended the authorisation for Dysport for symptomatic treatment of upper limb spasticity in children with cerebral palsy, aged two years and over.

This authorisation follows the phase III study which demonstrated that Dysport reduces the symptoms of spasticity in children aged two years and over, according to the Modified Ashworth Scale (MAS). No new security concerns have been identified.

"An estimated 1 in 400 babies born with cerebral palsy in the UK, 75-91% of whom will have a specific type known as spastic cerebral palsy," Ipsen said.

Copyright (c) 2020 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.